BioPharma Resources

Drugs by condition

Drugs approved for narcolepsy

Brand-name prescription drugs and biologics whose FDA label lists narcolepsy as an approved use. Matched on the label phrases: "narcolepsy".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

10

Still marketed, NDA or BLA

Drug classes

3

Novel drugs

3

New molecular entities and new biologics

In development

4

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for narcolepsy.

  • Lumryz (Sodium Oxybate) · Alkermes INC OrphanMay 1, 2023
  • Wakix (Pitolisant Hydrochloride) · Harmony Breakthrough therapyPriority reviewOrphanOct 13, 2020
  • Xywav (Calcium Oxybate, Magnesium Oxybate, Potassium Oxybate, Sodium Oxybate) · Jazz Priority reviewOrphanJul 21, 2020
  • Sunosi (Solriamfetol Hydrochloride) · Axsome Malta NovelOrphanMar 20, 2019
  • Nuvigil (Armodafinil) · Nuvo Pharms Jun 15, 2007

All approved drugs for narcolepsy, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 74 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Dopamine and Norepinephrine Reuptake Inhibitor (1)

  • Sunosi Solriamfetol Hydrochloride · Axsome Malta · 2019

Sympathomimetic-like Agent (1)

  • Provigil Modafinil · Nuvo Pharms · 1998

Class not listed in FDA's data (8)

  • Xyrem Sodium Oxybate · Jazz Pharms · 2002
  • Lumryz Sodium Oxybate · Alkermes INC · 2023
  • Wakix Pitolisant Hydrochloride · Harmony · 2020
  • Xywav Calcium Oxybate, Magnesium Oxybate, Potassium Oxybate, Sodium Oxybate · Jazz · 2020
  • Nuvigil Armodafinil · Nuvo Pharms · 2007
  • Methylin Methylphenidate Hydrochloride · Specgx LLC · 2002
  • Dexedrine Spansule Dextroamphetamine Sulfate · Impax Labs INC · 1976
  • Ritalin Methylphenidate Hydrochloride · Sandoz · 1955

Drugs in development for narcolepsy

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • ALKS 2680AlixorextonPhase 37 trials

    Alkermes, Inc. · Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia

  • TAK-360Phase 34 trials

    Takeda · Narcolepsy Type 1, Idiopathic Hypersomnia, Narcolepsy Type 2

  • ORX750Phase 22 trials

    Centessa Pharmaceuticals (UK) Limited · Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia

  • E2086Phase 21 trial

    Eisai · Narcolepsy

More on narcolepsy: recruiting trials · published research

Related in neurology: Alzheimer's disease · Parkinson's disease · Multiple sclerosis · Epilepsy and seizures · Migraine · ALS (amyotrophic lateral sclerosis) · Myasthenia gravis · Spinal muscular atrophy · Duchenne muscular dystrophy · Huntington's disease chorea

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.